A Study of Single and Multiple Oral Doses of TollB-001
Status:
Recruiting
Trial end date:
2024-06-09
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate the safety and tolerability of TollB-001 following the
administration of single or multiple oral doses in healthy adult subjects